Case number 2018-1257
Neptune Generics, LLC v. Eli Lilly & Company > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | NEPTUNE GENERICS, LLC v. ELI LILLY & COMPANY [OPINION - PRECEDENTIAL] [precedential] (0) |
| Jun 4, 2019 | 93 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [611269] [18-1257, 18-1258, 18-1288, 18-1290] [JAB] [Entered: 06/04/2019 10:56 AM] (0) |
| Apr 26, 2019 | 91 | OPINION filed for the court by Moore, Circuit Judge; Wallach, Circuit Judge and Hughes, Circuit Judge. Precedential Opinion. [603109] [18-1257, 18-1258, 18-1288, 18-1290] [JAB] [Entered: 04/26/2019 09:27 AM] (0) |
| Apr 26, 2019 | 92 | JUDGMENT filed. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [603114] [18-1257, 18-1258, 18-1288, 18-1290] [JAB] [Entered: 04/26/2019 09:30 AM] (0) |
| Feb 8, 2019 | 90 | **TEXT ONLY** ORDER granting motion to withdraw attorney Cynthia Lambert Hardman [89] filed by Appellant Fresenius Kabi USA, LLC. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [584307] [JAB] [Entered: 02/08/2019 07:29 AM] (0) |
| Feb 7, 2019 | 89 | MOTION of Appellant Fresenius Kabi USA, LLC to withdraw counsel Cynthia L. Hardman [Consent: unopposed]. Service: 02/07/2019 by email. [584067] [18-1257] [Michael Cottler] [Entered: 02/07/2019 12:11 PM] (0) |
| Feb 5, 2019 | 88 | Submitted after ORAL ARGUMENT by Ms. Sarah Elizabeth Spires for Neptune Generics, LLC, Fresenius Kabi USA, LLC and Mylan Laboratories Limited and Adam Lawrence Perlman for Eli Lilly & Company. Panel: Judge: Moore , Judge: Wallach , Judge: Hughes. [583431] [JCP] [Entered: 02/05/2019 11:16 AM] (0) |
| Jan 15, 2019 | 87 | Response to notice of oral argument from the Appellants Neptune Generics, LLC, Fresenius Kabi USA, LLC and Mylan Laboratories Limited. [578179] [18-1257] [Paul Skiermont] [Entered: 01/15/2019 03:24 PM] (0) |
| Jan 2, 2019 | 86 | Response to notice of oral argument from the Appellee Eli Lilly & Company. [575237] [18-1257] [Adam Perlman] [Entered: 01/02/2019 11:52 AM] (0) |
| Dec 17, 2018 | 85 | NOTICE OF ORAL ARGUMENT. Panel: 1902D. Case scheduled Feb 05, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to Notice of Oral Argument due: 01/15/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [572180] [JAB] [Entered: 12/17/2018 12:12 PM] (0) |
| Nov 2, 2018 | 84 | CORRECTED ENTRY: RESPONSE of Appellee Eli Lilly & Company to the supplemental authority [83] filed by Appellants Fresenius Kabi USA, LLC and Neptune Generics, LLC in 18-1257. Service: 11/02/2018 by email. [562412]--[Edited 11/06/2018 by SMJ - Reason: to correct submission event] [Adam Perlman] [Entered: 11/02/2018 07:10 PM] (0) |
| Oct 26, 2018 | 83 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants Neptune Generics, LLC and Fresenius Kabi USA, LLC. Service: 10/26/2018 by email. [560766] [18-1257] [Sarah Spires] [Entered: 10/26/2018 06:08 PM] (4) |
| Sep 4, 2018 | 82 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks [November, December, January], or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 09/11/2018. [546951] [CMP] [Entered: 09/04/2018 01:55 PM] (0) |
| Aug 30, 2018 | 81 | Notice from Appellant Mylan Laboratories Limited regarding conflicts with oral argument (October 15-19, 2018 and October 22-23, 2018). Service: 08/30/2018 by email. [546473] [18-1257] [Thomas Parker] [Entered: 08/30/2018 02:39 PM] (1) |
| Aug 29, 2018 | 80 | Notice from Appellee Eli Lilly & Company regarding conflicts with oral argument (October 1-5, 2018). Service: 08/29/2018 by email. [546264] [18-1257] [Adam Perlman] [Entered: 08/29/2018 05:52 PM] (1) |
| Aug 29, 2018 | 79 | 6 paper copies of the Joint Appendix Brief (Vol. I - V) [76] received from Appellants Fresenius Kabi USA, LLC, Mylan Laboratories Limited and Neptune Generics, LLC. [546160] [CJF] [Entered: 08/29/2018 03:04 PM] (0) |
| Aug 28, 2018 | 78 | Amended Certificate of Interest for the Appellee Eli Lilly & Company. Service: 08/28/2018 by email. [545934] [18-1257] [Adam Perlman] [Entered: 08/28/2018 05:28 PM] (3) |
| Aug 28, 2018 | 77 | Notice from Appellant Neptune Generics, LLC regarding conflicts with oral argument (October 10, 2018; October 15-19, 2018; November 15-16, 2018; November 19-23, 2018; November 30, 2018; December 7, 2018; and December 24, 2018-January 2, 2019). Service: 08/28/2018 by email. [545933] [18-1257] [Mieke Malmberg] [Entered: 08/28/2018 05:17 PM] (4) |
| Aug 23, 2018 | 76 | APPENDIX FILED for Fresenius Kabi USA, LLC, Mylan Laboratories Limited and Neptune Generics, LLC [75]. Number of Pages: 2760. Service: 08/23/2018 by email. The paper copies of the brief should be received by the court on or before 09/04/2018. [545500] [CMP] [Entered: 08/27/2018 10:29 AM] (2760) |
| Aug 23, 2018 | 75 | TENDERED from Appellee Eli Lilly & Company and Appellants Fresenius Kabi USA, LLC, Mylan Laboratories Limited and Neptune Generics, LLC. Title: JOINT APPENDIX. Service: 08/23/2018 by email. [544971] [18-1257] [Thomas Parker] [Entered: 08/23/2018 02:15 PM] (2760) |
| Aug 22, 2018 | 74 | Amended Certificate of Interest for the Appellant Neptune Generics, LLC. Service: 08/22/2018 by email. [544647] [18-1257] [Mieke Malmberg] [Entered: 08/22/2018 12:45 PM] (6) |
| Aug 22, 2018 | 73 | 6 paper copies of the Reply Brief [70] received from Appellants Fresenius Kabi USA, LLC, Mylan Laboratories Limited and Neptune Generics, LLC. [544628] [CJF] [Entered: 08/22/2018 11:56 AM] (0) |
| Aug 21, 2018 | 72 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellee Eli Lilly & Company and Appellants Fresenius Kabi USA, LLC, Mylan Laboratories Limited and Neptune Generics, LLC. Service: 08/21/2018 by email. [544507] [18-1257] [Mieke Malmberg] [Entered: 08/21/2018 05:26 PM] (5) |
| Aug 21, 2018 | 71 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [544308] [CMP] [Entered: 08/21/2018 11:23 AM] (0) |
| Aug 16, 2018 | 70 | REPLY BRIEF FILED for Appellants Fresenius Kabi USA, LLC, Mylan Laboratories Limited and Neptune Generics, LLC [69]. Number of Pages: 32. Service: 08/16/2018 by email. The paper copies of the brief should be received by the court on or before 08/28/2018. Appendix is due 08/23/2018. [544307] [CMP] [Entered: 08/21/2018 11:23 AM] (52) |
| Aug 16, 2018 | 69 | TENDERED from Appellants Mylan Laboratories Limited, Neptune Generics, LLC and Fresenius Kabi USA, LLC. Title: REPLY BRIEF. Service: 08/16/2018 by email. [543540] [18-1257] [Thomas Parker] [Entered: 08/16/2018 05:28 PM] (52) |
| Aug 10, 2018 | 68 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Joshua Harris (entry of appearance [67]) is not a registered CM/ECF filer with the Federal Circuit. CORRECTION: Pursuant to FCR 25(a)(2), attorneys who appear before this court must register for the court's CM/ECF system. Please register promptly. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [541926] [SJL] [Entered: 08/10/2018 08:41 AM] (0) |
| Aug 9, 2018 | 66 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Neptune Generics, LLC, Entry of appearance for Joshua Harlan Harris [65], is not in compliance with the rules of this court (see attached). Entry of appearance for Appellant Neptune Generics, LLC is due on or before 08/16/2018. Service as of this date by the Clerk of Court.[541753] [SJL] [Entered: 08/09/2018 12:38 PM] (1) |
| Aug 9, 2018 | 67 | Corrected Entry of appearance for Joshua Harlan Harris as of counsel for Appellant Neptune Generics, LLC. Service: 08/09/2018 by email. [541765] [18-1257] [Mieke Malmberg] [Entered: 08/09/2018 01:13 PM] (2) |
| Aug 6, 2018 | 65 | Entry of appearance for Joshua Harlan Harris as of counsel for Appellant Neptune Generics, LLC. Service: 08/06/2018 by email. [540875] [18-1257] This document is non-compliant. See Doc. No. [66] [Mieke Malmberg] [Entered: 08/06/2018 11:09 AM] (1) |
| Jul 31, 2018 | 64 | Entry of appearance for James P. Leeds as of counsel for Appellee Eli Lilly & Company. Service: 07/31/2018 by email. [539878] [18-1257] [James Leeds] [Entered: 07/31/2018 05:05 PM] (2) |
| Jul 27, 2018 | 63 | 6 paper copies of the Opening Response Brief [62] received from Appellee Eli Lilly & Company. [539025] [CJF] [Entered: 07/27/2018 11:57 AM] (0) |
| Jul 19, 2018 | 62 | BRIEF FILED for Appellee Eli Lilly & Company [61]. Number of Pages: 68. Service: 07/19/2018 by email. The paper copies of the brief should be received by the court on or before 07/31/2018. Appellants Fresenius Kabi USA, LLC, Mylan Laboratories Limited and Neptune Generics, LLC reply brief is due 08/16/2018. [538050] [CMP] [Entered: 07/24/2018 09:14 AM] (80) |
| Jul 19, 2018 | 61 | TENDERED from Appellee Eli Lilly & Company. Title: RESPONSE BRIEF. Service: 07/19/2018 by email. [537141] [18-1257] [Adam Perlman] [Entered: 07/19/2018 07:27 PM] (80) |
| Jul 19, 2018 | 60 | Entry of appearance for Charles L. McCloud as of counsel for Appellee Eli Lilly & Company. Service: 07/19/2018 by email. [537137] [18-1257] [Charles McCloud] [Entered: 07/19/2018 06:32 PM] (2) |
| Jul 18, 2018 | 59 | **TEXT ONLY** ORDER granting motion to withdraw attorney Yi Wen Wu [58] filed by Appellant Mylan Laboratories Limited. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [536799] [CMP] [Entered: 07/18/2018 02:05 PM] (0) |
| Jul 18, 2018 | 58 | MOTION of Appellant Mylan Laboratories Limited to withdraw counsel Yi Wen Wu [Consent: not addressed]. Service: 07/18/2018 by email. [536788] [18-1257] [Thomas Parker] [Entered: 07/18/2018 01:46 PM] (5) |
| Jul 3, 2018 | 57 | **TEXT ONLY** ORDER granting motion to withdraw Ellen Y. Cheong as counsel [56] filed by Appellant Mylan Laboratories Limited. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [533540] [CFT] [Entered: 07/03/2018 03:39 PM] (0) |
| Jul 3, 2018 | 56 | MOTION of Appellant Mylan Laboratories Limited to withdraw counsel Ellen Y. Cheong [Consent: not addressed]. Service: 07/03/2018 by email. [533335] [18-1257] [Thomas Parker] [Entered: 07/03/2018 10:13 AM] (5) |
| Jun 29, 2018 | 55 | Entry of appearance for Andrew P. Lemens as of counsel for Appellee Eli Lilly & Company. Service: 06/29/2018 by email. [532904] [18-1257] [Andrew Lemens] [Entered: 06/29/2018 03:27 PM] (2) |
| May 21, 2018 | 54 | ORDER filed. The appellee's response brief is due no later than July 19, 2018. Service: 05/21/2018 by clerk. [523286] [LMS] [Entered: 05/21/2018 02:44 PM] (2) |
| May 18, 2018 | 53 | ORDER filed. The motion to withdraw party [52] is granted. The revised official caption is reflected in the order.; Eli Lilly’s response brief is due within 40 days of the date of this order. Service: 05/18/2018 by clerk. [523029] [NL] [Entered: 05/18/2018 05:26 PM] (2) |
| May 17, 2018 | 52 | MOTION of Appellants Apotex Corp., Apotex Inc. and Appellee Eli Lilly & Company to withdraw party, Apotex Inc. and Apotex Corp., as a party to this appeal [Consent: unopposed]. Service: 05/17/2018 by email. [522448] [18-1257] [William Rakoczy] [Entered: 05/17/2018 10:53 AM] (8) |
| May 11, 2018 | 51 | 6 paper copies of the Opening Brief [50] received from Appellants Fresenius Kabi USA, LLC, Mylan Laboratories Limited and Neptune Generics, LLC. [521025] [JCP] [Entered: 05/11/2018 11:51 AM] (0) |
| May 10, 2018 | 50 | BRIEF FILED for Appellants Fresenius Kabi USA, LLC, Mylan Laboratories Limited and Neptune Generics, LLC [48]. Number of Pages: 65. Service: 05/07/2018 by email. The paper copies of the brief should be received by the court on or before 05/17/2018. [520755] [CMP] [Entered: 05/10/2018 03:14 PM] (360) |
| May 10, 2018 | 49 | ORDER filed. Neptune Generics, Mylan Laboratories, and Fresenius Kabi USA's opening brief is accepted for filing. Apotex's opening brief is due within seven days of the date of filing of this order. Appellee should calculate its brief due date from the earlier of the date of filing of Apotex's opening brief or from the date Apotex's brief is due. Service: 05/10/2018 by clerk. [520747] [LMS] [Entered: 05/10/2018 03:04 PM] (2) |
| May 7, 2018 | 48 | TENDERED from Appellants Mylan Laboratories Limited, Neptune Generics, LLC and Fresenius Kabi USA, LLC. Title: OPENING BRIEF. Service: 05/07/2018 by email. [519779] [18-1257] [Thomas Parker] [Entered: 05/07/2018 04:36 PM] (360) |
| May 3, 2018 | 47 | Amended Certificate of Interest for the Appellant Fresenius Kabi USA, LLC. Service: 05/03/2018 by email. [518999] [18-1257] [Michael Cottler] [Entered: 05/03/2018 05:28 PM] (3) |
| May 2, 2018 | 46 | ORDER filed. The stay of the briefing schedule is lifted.; Neptune Generics and Mylan Laboratories Limited’s opening brief, not to exceed 15,500 words is due no later than May 7, 2018. Service: 05/02/2018 by clerk. [518418] [NL] [Entered: 05/02/2018 11:21 AM] (2) |
| May 2, 2018 | 45 | ORDER filed. The motion [43] is granted. Service: 05/02/2018 by clerk. [518414] [NL] [Entered: 05/02/2018 11:17 AM] (2) |
| Apr 30, 2018 | 44 | ORDER filed. The briefing schedule is stayed pending the court’s disposition of the motion. Service: 04/30/2018 by clerk. [517836] [NL] [Entered: 04/30/2018 04:26 PM] (2) |
| Apr 25, 2018 | 43 | MOTION of Appellants Mylan Laboratories Limited and Neptune Generics, LLC to waive the requirements regarding the brief (Motion for Leave to File an Opening Brief Enlarged by 1,500 Words [Fed.Cir.R. 28(c)]) [Consent: unopposed]. Service: 04/25/2018 by email. [516782] [18-1257] [Sarah Spires] [Entered: 04/25/2018 01:46 PM] (13) |
| Apr 2, 2018 | 42 | **TEXT ONLY** ORDER granting motion to withdraw attorney Patrick C. Kilgore [40] filed by Appellants Apotex Inc. and Apotex Corp.. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [509926] [CMP] [Entered: 04/02/2018 03:38 PM] (0) |
| Mar 28, 2018 | 40 | MOTION of Appellants Apotex Corp. and Apotex Inc. to withdraw counsel Patrick C. Kilgore. Any response is due within 10 days of service. [Consent: unopposed]. Service: 03/28/2018 by email. [508846] [18-1257] [William Rakoczy] [Entered: 03/28/2018 05:38 PM] (6) |
| Mar 28, 2018 | 41 | Entry of appearance for Cynthia H. Sun as of counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 03/28/2018 by email. [508862] [18-1257] [William Rakoczy] [Entered: 03/28/2018 06:08 PM] (2) |
| Mar 15, 2018 | 39 | ORDER granting motion to extend time to file appellant principal brief until 05/04/18, appellee principal brief until 07/19/18, and appellant reply brief until 08/16/18 filed by Appellant Mylan Laboratories Limited [38]. Service as of this date by the Clerk of Court. [505682] [CMP] [Entered: 03/15/2018 03:59 PM] (2) |
| Mar 9, 2018 | 38 | MOTION of Appellant Mylan Laboratories Limited to extend the time to 05/04/2018 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service, to extend the time to 07/19/2018 at 11:59 pm to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service, to extend the time to 08/16/2018 at 11:59 pm to file the reply brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/09/2018 by email. [503985] [Thomas Parker] [Entered: 03/09/2018 05:15 PM] (20) |
| Mar 9, 2018 | 37 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [503766] [CMP] [Entered: 03/09/2018 11:36 AM] (0) |
| Mar 5, 2018 | 36 | ORDER filed. The motion to withdraw [35] is granted. The motion to deconsolidate [29] is withdrawn. Service: by. [502504] [LMS] [Entered: 03/05/2018 12:06 PM] (2) |
| Mar 1, 2018 | 35 | MOTION of Appellant Mylan Laboratories Limited to withdraw [29] motion to deconsolidate appeals filed by Appellant Mylan Laboratories Limited in 18-1257. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/01/2018 by email. [502183] [Thomas Parker] [Entered: 03/01/2018 04:47 PM] (7) |
| Feb 23, 2018 | 34 | ORDER granting motion to extend time to file a response/reply [33] filed by Appellant Mylan Laboratories Limited.; Mylan Laboratories Limited's reply in support of its motion to deconsolidate is due on or before 03/01/2018. Service: 02/23/2018 by clerk. [500588] [NL] [Entered: 02/23/2018 10:11 AM] (2) |
| Feb 22, 2018 | 33 | MOTION of Appellant Mylan Laboratories Limited to extend the time to 03/01/2018 file a response/reply to the motion to deconsolidate appeals [29]. [Consent: unopposed]. Service: 02/22/2018 by email. [500498] [Thomas Parker] [Entered: 02/22/2018 07:47 PM] (8) |
| Feb 15, 2018 | 32 | RESPONSE of Appellee Eli Lilly & Company to the motion to deconsolidate appeals [29] filed by Appellant Mylan Laboratories Limited in 18-1257. Service: 02/15/2018 by email. [498339] [Adam Perlman] [Entered: 02/15/2018 07:36 PM] (25) |
| Jan 30, 2018 | 31 | ORDER filed. The motion [30] is granted. Service: 01/30/2018 by clerk. [493777] [18-1257, 18-1288] [NL] [Entered: 01/30/2018 03:35 PM] (2) |
| Jan 29, 2018 | 30 | MOTION of Appellee Eli Lilly & Company to extend the time to 02/15/2018 at 11:59 pm file a response/reply to the motion to deconsolidate appeals [29]. [Consent: unopposed]. Service: 01/29/2018 by email. [493526] [Adam Perlman] [Entered: 01/29/2018 08:52 PM] (5) |
| Jan 25, 2018 | 29 | MOTION of Appellant Mylan Laboratories Limited to deconsolidate appeals. Any response is due within 10 days of service [Consent: opposed]. Service: 01/25/2018 by email. [492874] [Thomas Parker] [Entered: 01/25/2018 06:38 PM] (285) |
| Jan 24, 2018 | 28 | Certified list from the United States Patent and Trademark Office. Service: 01/23/2018 by email. Appellant's brief is due 03/26/2018. [492446] [18-1257, 18-1258, 18-1288, 18-1290] [CMP] [Entered: 01/24/2018 04:13 PM] (295) |
| Dec 27, 2017 | 27 | Note to file: The following cases are associated: 18-1257 Lead with 18-1258, 18-1288, 18-1290 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [485717] [18-1257, 18-1258, 18-1288, 18-1290] [CMP] [Entered: 12/27/2017 09:47 AM] (0) |
| Dec 27, 2017 | 26 | ORDER consolidating appeals (18-1257, 18-1288) and modifying the official caption in 18-1257. The revised official caption is reflected in the Order. The certified lists are due no later than January 22, 2018. Service as of this date by Clerk of Court. [485706] [18-1257, 18-1288] [CMP] [Entered: 12/27/2017 09:29 AM] (2) |
| Dec 22, 2017 | 25 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Joseph T. Jaros (entry of appearance [15]) is not a registered CM/ECF filer with the Federal Circuit. CORRECTION: Pursuant to FCR 25(a)(2), attorneys who appear before this court must register for the court's CM/ECF system. Please register promptly. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [485098] [CMP] [Entered: 12/22/2017 08:50 AM] (0) |
| Dec 20, 2017 | 20 | Docketing Statement for the Appellee Eli Lilly & Company. Service: 12/20/2017 by email. [484540] [Adam Perlman] [Entered: 12/20/2017 09:28 PM] (4) |
| Dec 20, 2017 | 24 | Entry of appearance for Galina I. Fomenkova as of counsel for Appellee Eli Lilly & Company. Service: 12/20/2017 by email. [484550] [Galina Fomenkova] [Entered: 12/20/2017 09:45 PM] (2) |
| Dec 20, 2017 | 23 | Entry of appearance for David M. Krinsky as of counsel for Appellee Eli Lilly & Company. Service: 12/20/2017 by email. [484548] [David Krinsky] [Entered: 12/20/2017 09:41 PM] (2) |
| Dec 20, 2017 | 22 | Entry of appearance for Dov P. Grossman as of counsel for Appellee Eli Lilly & Company. Service: 12/20/2017 by email. [484546] [Dov Grossman] [Entered: 12/20/2017 09:38 PM] (2) |
| Dec 20, 2017 | 21 | Certificate of Interest for the Appellee Eli Lilly & Company. Service: 12/20/2017 by email. [484541] [Adam Perlman] [Entered: 12/20/2017 09:30 PM] (4) |
| Dec 20, 2017 | 19 | Entry of appearance for Adam L. Perlman as principal counsel for Appellee Eli Lilly & Company. Service: 12/20/2017 by email. [484539] [Adam Perlman] [Entered: 12/20/2017 09:26 PM] (2) |
| Dec 20, 2017 | 18 | Docketing Statement for the Appellants Apotex Corp. and Apotex Inc.. Service: 12/20/2017 by email. [484524] [Patrick Kilgore] [Entered: 12/20/2017 06:22 PM] (3) |
| Dec 20, 2017 | 17 | Certificate of Interest for the Appellants Apotex Corp. and Apotex Inc.. Service: 12/20/2017 by email. [484521] [Patrick Kilgore] [Entered: 12/20/2017 06:18 PM] (4) |
| Dec 20, 2017 | 16 | Entry of appearance for Patrick C. Kilgore as of counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 12/20/2017 by email. [484520] [Patrick Kilgore] [Entered: 12/20/2017 06:15 PM] (2) |
| Dec 20, 2017 | 15 | Entry of appearance for Joseph T. Jaros as of counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 12/20/2017 by email. [484519] [Patrick Kilgore] [Entered: 12/20/2017 06:13 PM] (2) |
| Dec 20, 2017 | 14 | Entry of appearance for William A. Rakoczy as principal counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 12/20/2017 by email. [484516] [Patrick Kilgore] [Entered: 12/20/2017 06:10 PM] (2) |
| Dec 20, 2017 | 13 | Certificate of Interest for the Appellant Fresenius Kabi USA, LLC. Service: 12/20/2017 by email. [484256] [Michael Cottler] [Entered: 12/20/2017 01:33 PM] (3) |
| Dec 20, 2017 | 12 | Docketing Statement for the Appellant Fresenius Kabi USA, LLC. Service: 12/20/2017 by email. [484254] [Michael Cottler] [Entered: 12/20/2017 01:32 PM] (3) |
| Dec 20, 2017 | 11 | Entry of appearance for Cynthia Lambert Hardman as of counsel for Appellant Fresenius Kabi USA, LLC. Service: 12/20/2017 by email. [484253] [Michael Cottler] [Entered: 12/20/2017 01:30 PM] (2) |
| Dec 20, 2017 | 10 | Entry of appearance for Michael B. Cottler as principal counsel for Appellant Fresenius Kabi USA, LLC. Service: 12/20/2017 by email. [484248] [Michael Cottler] [Entered: 12/20/2017 01:28 PM] (2) |
| Dec 20, 2017 | 9 | Entry of appearance for Mieke K. Malmberg as of counsel for Appellant Neptune Generics, LLC. Service: 12/20/2017 by email. [484212] [Mieke Malmberg] [Entered: 12/20/2017 12:34 PM] (2) |
| Dec 20, 2017 | 8 | Entry of appearance for Paul J. Skiermont as principal counsel for Appellant Neptune Generics, LLC. Service: 12/20/2017 by email. [484209] [Paul Skiermont] [Entered: 12/20/2017 12:30 PM] (2) |
| Dec 20, 2017 | 7 | Entry of appearance for Sarah E. Spires as of counsel for Appellant Neptune Generics, LLC. Service: 12/20/2017 by email. [484195] [Sarah Spires] [Entered: 12/20/2017 12:17 PM] (2) |
| Dec 20, 2017 | 6 | Certificate of Interest for the Appellant Neptune Generics, LLC. Service: 12/20/2017 by email. [484191] [Sarah Spires] [Entered: 12/20/2017 12:14 PM] (4) |
| Dec 20, 2017 | 5 | Docketing Statement for the Appellant Neptune Generics, LLC. Service: 12/20/2017 by email. [484188] [Sarah Spires] [Entered: 12/20/2017 12:12 PM] (4) |
| Dec 11, 2017 | 3 | ORDER consolidating appeals (18-1257, 18-1258). The revised official caption is reflected in the Order. The certified lists are due no later than January 16, 2018. Service as of this date by Clerk of Court. [481524] [18-1257, 18-1258] [CMP] [Entered: 12/11/2017 11:12 AM] (2) |
| Dec 11, 2017 | 4 | Note to file: The following cases are associated: 18-1257 Lead with 18-1258 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [481527] [18-1257, 18-1258] [CMP] [Entered: 12/11/2017 11:16 AM] (0) |
| Dec 6, 2017 | 1 | Appeal docketed. Received: 12/04/2017. [480538] Entry of Appearance due 12/20/2017. Certificate of Interest is due on 12/20/2017. Docketing Statement due 12/20/2017. Certified List due on 01/16/2018. [CMP] [Entered: 12/06/2017 11:16 AM] (96) |
| Dec 6, 2017 | 2 | Amended Notice of Appeal for Neptune Generics, LLC, Fresenius Kabi USA, LLC, Apotex Inc., and Apotex Corp. Service: 12/06/2017 by email, US mail. [480820] [Sarah Spires] [Entered: 12/06/2017 07:19 PM] (95) |
